You are not connected
36
3
ORIXHA
Company
|
France
Primary tabs
About your organization
Orixha’s mission is to develop Liquid Ventilation Medical Devices to save lives in Critical Care.
Orixha develops Vent2Cool based on its proprietary Lung Conservative Liquid Ventilation to shield the critical organs (brain, heart) from reperfusion injury. Vent2Cool improves survival and morbidity outcomes of Post Cardiac Arrest Syndrome by transforming the lungs into an efficient heat exchanger with the circulating blood to induce ultra-rapid therapeutic hypothermia – reaching the 33°C protective temperature within minutes vs. hours with current hypothermia devices.
Orixha’s proprietary total liquid ventilation technology platform, once validated in therapeutic hypothermia, will be developed for other Critical Care conditions such as Acute Respiratory Distress Syndrome.
Network (0)
There are no organizations in the network.